DOCSLIB.ORG

Read the Summer 2021 Newsletter

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Read the Summer 2021 Newsletter CCR Fellows & Young Investigators Newsletter Center for Cancer Research Volume 20, Issue 3 Summer 2021 CCR-FYI Newsletter Team Special newsletter edition: 21st CCR FYI Colloquium EDITOR IN CHIEF – From Mechanisms to Therapies: Alida Palmisano Current Highlights in Cancer Research MANAGING EDITOR – Annan Timon EDITORS – Enitome Bafor Sarah Burnash Dorothy L. Butler Molly Congdon Jessica Eisenstatt Amy Funk Mary Grace Katusiime Victoria Hill Sarwat Naz Carlos Villapudua CONTRIBUTORS – Srikanta Basu Dorothy Butler Sunita Chopra Molly Congdon Mary Grace Katusiime Katelyn Ludwig Isita Jhulki Babul Ram Geraldine Vilmen In the picture above, the CCR-FYI Colloquium Planning Committee: CCR-FYI Association is Chairs: Srikanta Basu, Katelyn Ludwig. Vice Chairs: Dorothy L. Butler, Anna Ratliff. supported by the NCI Knicki Bergman, Molly Congdon, Ruchika Bhujbalrao, Vasty Osei Amponsa, Sabina Kaczanowska, Center for Cancer Training Neha Wali, Joshua Rose, Sunita Chopra, Isita Jhulki, Mary Grace Katusiime, Sumirtha Balaratnam. (CCT) and CCR Office of Not in the picture, but part of the Planning Committee: Cassey Singler, Jose Delgado the Director. Support of the CCT-Office of Training and Education, CCR-FYI SC and CBIIT was essential for the success of this event, in particular the Committee wants to thank Amy Funk, Jessica Connect with CCR-FYI Eisenstatt, Angela Jones, Robert Montano, Erika Ginsburg and Oliver Bogler. VOLUME 20 – ISSUE 3 – SUMMER 2021 While the COVID-19 pandemic continues to have a major impact on the life of many NCI fellows, we are happy to see that one of the big CCR events of the year (the CCR-FYI Colloquium) returned in 2021 after being cancelled in 2020. Even though this annual two-day event was held virtually in April 2021, fellows and young investigators had the chance to participate in keynote addresses from extramural and intramural speakers along with panels and workshops to highlight the career development of CCR fellows. In this edition of the Newsletter we feature summaries of each section of the Colloquium, to give anyone who was not able to attend the chance to get some of the valuable insights and information that was shared by speakers and panelists. And if you want to listen to some of the workshops or panels again, make sure to click the links to the video recordings of the event! I hope you enjoy reading the Summer 2021, Special edition of the FYI Newsletter! – Alida Palmisano (Editor-In-Chief) (background image created with BioRender.com and picture by guy stevens on Unsplash) Inside this issue 2021 CCR-FYI Colloquium Awards .................................................................................................................................................. 2 Opening Remarks from Colloquium Planning Committee Chairs ...................................................................................... 3 Watch the recordings of the CCR-FYI Colloquium! .................................................................................................................. 4 Remarks from the NCI Director, Dr. Sharpless ........................................................................................................................... 5 “The Role of Multidrug Transporters in Drug Resistance in Cancer” .................................................................................. Keynote talk: Dr. Michael M. Gottesman ...................................................................................................................................... 6 “Release of PKC from Quarantine by mTORC2” Keynote talk: Dr. Alexandra Newton ............................................... 8 Management Techniques (Workshop hosted by Shannon Bell) ....................................................................................... 11 Careers in Academia: A summary of the Panel Discussion.................................................................................................. 13 Panel Discussion: Non-profit Organizations ............................................................................................................................. 16 DNA-based Vaccines: an emerging technique for safe and efficient vaccination ......................................................... (Keynote talk: Dr. Barbara Felber) ................................................................................................................................................. 20 CCR Directors’ Addresses ................................................................................................................................................................. 22 From Past to Future: Catching up with the Founding Director of the CCR ................................................................... 24 Marty Tenenbaum, Computer Scientist and Cancer Survivor, delivers a clarion call to redesign oncology .... 25 Virtual Interview Techniques (Workshop by Scott Morgan) ............................................................................................... 28 “Networking -The open secret for a highly successful scientist” (Workshop by Dr. Phil Ryan) ............................ 30 Advice from the 2021 CCR-FYI Colloquium Drug Development and Industry Career Panel ................................. 33 CCR FYI Newsletter p. 1 VOLUME 20 – ISSUE 3 – SUMMER 2021 2021 CCR-FYI Colloquium Awards CCR FYI Newsletter p. 2 VOLUME 20 – ISSUE 3 – SUMMER 2021 Opening Remarks from Colloquium Planning Committee Chairs by: Srikanta Basu and Katelyn Ludwig The 21st Annual CCR-FYI Colloquium, entitled of the Colloquium, Dr. Barbara Felber, a Senior “From Mechanisms to Therapies: Current Investigator in the Vaccine Branch and Head of Highlights in Cancer Research,” took place on the Human Retrovirus Pathogenesis Section at April 19-20th, 2021. In response to the COVID-19 the NIH, delivered her talk entitled “DNA vaccine pandemic, the Colloquium was held virtually for for Broad and Durable Immunity.” Additionally, the second year in a row. Despite these we heard a talk from Dr. Sachi Horibata, who was circumstances, we strove to design an event selected as the 2021 Outstanding Postdoctoral featuring scientifically diverse topics and fellow awardee. Dr. Horibata spoke about professional development opportunities to “Identifying underlying determinants of develop the skills of the CCR fellows. chemotherapy resistance in cancer,” and she detailed her work examining distinct gene profiles The first day of the Colloquium began with in refractory acute myeloid leukemia. opening remarks by Dr. Srikanta Basu, the CCR- FYI Colloquium Planning Committee co-chair In addition, we hosted two extramural speakers from Frederick. Next, Erika Ginsburg, the Chief of and one survivorship speaker. Dr. Alexandra the Office of Training and Education, Center for Newton, a Distinguished Professor of Cancer Training (CCT), spoke about the resources Pharmacology at the University of California, San available for the CCR fellows, including fellowship Diego, spoke about “Reversing the Paradigm: opportunities. The attendees then heard from Dr. Protein Kinase C as a Tumor Suppressor.” On the Oliver Bogler, the Director of the CCT, regarding second day of the Colloquium, Dr. J. Carl Barrett, the current directives of the CCT and its future the Vice President of Oncology and Translational directions. We also heard remarks from Dr. Ned Sciences at AstraZeneca, and the founding Sharpless, the Director of the NCI. The second Director of the CCR, spoke about “Translational day of the Colloquium was also opened with talks Medicine in Driving Drug Development in by NCI leadership including Dr. Glenn Merlino, Oncology.” Next, we heard from Dr. Marty the CCR Scientific Director for Basic Research, and Tenenbaum, a computer scientist and cancer Dr. William Dahut, the CCR Scientific Director for survivor. He is the founder of Cancer Commons Clinical Research, who spoke about the ongoing and CollabRx, and he spoke about his experience work at the NCI, including an update on the as a cancer patient as well as the work he does in clinical trials in progress. the cancer field as a computer scientist. Over the course of the two days, we hosted two Finally, we hosted concurrent oral presentations intramural keynote speakers from the NCI. The and virtual poster presentations to provide the first was Dr. Michael Gottesman, the Deputy CCR fellows with opportunities to share their Director for Intramural Research & Chief of the work. We also hosted three panels and three Laboratory of Cell Biology. Dr. Gottesman gave a workshops covering topics related to professional talk entitled “The Role of Multidrug Transporters development. Two panels covered academia and in Drug Resistance in Cancer.” On the second day CCR FYI Newsletter p. 3 VOLUME 20 – ISSUE 3 – SUMMER 2021 industry career topics, while the last panel all their help designing a virtual colloquium. We focused on scientific opportunities at nonprofit would also like to thank the CCR-FYI volunteers organizations. Additionally, we hosted workshops that helped plan and run the 2021 Colloquium. on virtual interview techniques, scientific communication, and management techniques, to If you would like to get involved in the CCR-FYI enhance the non-technical skills of the CCR and the planning of the 2022 Colloquium, fellows. please contact either Dorothy Butler ([email protected]) or The articles in this edition of the CCR-FYI Anna Ratliff ([email protected]) for more Newsletter summarize the details of the events
Load more

Recommended publications
  • Lipid Metabolism Has Been Good to Me George M
    REFLECTIONS Lipid metabolism has been good to me https://doi.org/10.1016/j.jbc.2021.100786 George M. Carman* From the Department of Food Science and the Rutgers Center for Lipid Research, New Jersey Institute for Food, Nutrition, and Health, Rutgers University, New Brunswick, New Jersey, USA Edited by the Reflections and Classics Committee headed by Patrick Sung My career in research has flourished through hard work, program director of the National Science Foundation), supportive mentors, and outstanding mentees and collabora- encouraged me to pursue a research career in biochemistry; tors. The Carman laboratory has contributed to the under- she continues to be a mentor and friend. My MS degree standing of lipid metabolism through the isolation and advisor, John Keller, introduced me to laboratory research characterization of key lipid biosynthetic enzymes as well as and gave me an appreciation for science in a broader context through the identification of the enzyme-encoding genes. Our by encouraging me to attend meetings of the Theobald Smith findings from yeast have proven to be invaluable to understand Society for Microbiology (local branch of the American So- regulatory mechanisms of human lipid metabolism. Several ciety for Microbiology). He also encouraged me to apply to rewarding aspects of my career have been my service to the the University of Massachusetts (PhD, 1977) where Robert Journal of Biological Chemistry as an editorial board member Levin had an open graduate research position in food and Associate Editor, the National Institutes of Health as a microbiology. I did not realize that my PhD degree would be member of study sections, and national and international sci- in Food Science or that I would have to take undergraduate entific meetings as an organizer.
    [Show full text]
  • Protein Kinase Cζ Exhibits Constitutive Phosphorylation and Phosphatidylinositol-3,4,5-Triphosphate-Independent Regulation Irene S
    Biochem. J. (2016) 473, 509–523 doi:10.1042/BJ20151013 509 Protein kinase Cζ exhibits constitutive phosphorylation and phosphatidylinositol-3,4,5-triphosphate-independent regulation Irene S. Tobias*†, Manuel Kaulich‡, Peter K. Kim§, Nitya Simon*, Estela Jacinto§, Steven F. Dowdy‡, Charles C. King and Alexandra C. Newton*1 *Department of Pharmacology, University of California San Diego, La Jolla, CA 92093, U.S.A. †Biomedical Sciences Graduate Program, University of California San Diego, La Jolla, CA 92093, U.S.A. ‡Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, U.S.A. §Department of Biochemistry and Molecular Biology, Rutgers-Robert Wood Johnson Medical School, Piscataway, NJ 08854, U.S.A. Department of Pediatrics, University of California San Diego, La Jolla, CA 92093, U.S.A. Atypical protein kinase C (aPKC) isoenzymes are key modulators and insulin unresponsive, in marked contrast to the insulin- of insulin signalling, and their dysfunction correlates with insulin- dependent activation of Akt monitored by an Akt-specific reporter. resistant states in both mice and humans. Despite the engaged Nor does forced recruitment to phosphoinositides by fusing interest in the importance of aPKCs to type 2 diabetes, much the pleckstrin homology (PH) domain of Akt to the kinase less is known about the molecular mechanisms that govern their domain of PKCζ alter either the phosphorylation or activity cellular functions than for the conventional and novel PKC of PKCζ . Thus, insulin stimulation does not activate PKCζ isoenzymes and the functionally-related protein kinase B (Akt) through the canonical phosphatidylinositol-3,4,5-triphosphate- family of kinases.
    [Show full text]
  • Falke-Single Molecule Studies Kinase C-Biochemistry-14.Pdf
    Article pubs.acs.org/biochemistry Single-Molecule Studies Reveal a Hidden Key Step in the Activation Mechanism of Membrane-Bound Protein Kinase C‑α † ‡ † § † ∥ ‡ Brian P. Ziemba, Jianing Li, Kyle E. Landgraf, , Jefferson D. Knight, , Gregory A. Voth, † and Joseph J. Falke*, † Department of Chemistry and Biochemistry and Molecular Biophysics Program, University of Colorado, Boulder, Colorado 80309-0596, United States ‡ Department of Chemistry, Institute of Biophysical Dynamics, James Franck Institute, and Computation Institute, University of Chicago, Chicago, Illinois 60637, United States *S Supporting Information ABSTRACT: Protein kinase C-α (PKCα) is a member of the conventional family of protein kinase C isoforms (cPKCs) that regulate diverse cellular signaling pathways, share a common activation mechanism, and are linked to multiple pathologies. The cPKC domain structure is modular, consisting of an N-terminal pseudosubstrate peptide, two inhibitory domains (C1A and C1B), a targeting domain (C2), and a kinase domain. Mature, cytoplasmic cPKCs are inactive until they are switched on by a multistep activation reaction that occurs largely on the plasma membrane surface. Often, this activation begins with a cytoplasmic Ca2+ signal that triggers C2 domain targeting to the plasma membrane where it binds phosphatidylserine (PS) and phosphatidylinositol 4,5-bisphosphate (PIP2). Subsequently, the appearance of the signaling lipid diacylglycerol (DAG) activates the membrane-bound enzyme by recruiting the inhibitory pseudosubstrate and one or both C1 domains away from the kinase domain. To further investigate this mechanism, this study has utilized single-molecule total internal reflection fluorescence microscopy (TIRFM) to quantitate the binding and lateral diffusion of full-length PKCα and fragments missing specific domain(s) on supported lipid bilayers.
    [Show full text]
  • Kinetics and Mechanism of the Interaction of Protein
    UC San Diego UC San Diego Electronic Theses and Dissertations Title Kinetics and mechanism of the interaction of the C1 domain of protein kinase C with lipid membranes Permalink https://escholarship.org/uc/item/1vw5x6bm Author Dries, Daniel Robert Publication Date 2007 Peer reviewed|Thesis/dissertation eScholarship.org Powered by the California Digital Library University of California UNIVERSITY OF CALIFORNIA, SAN DIEGO KINETICS AND MECHANISM OF THE INTERACTION OF THE C1 DOMAIN OF PROTEIN KINASE C WITH LIPID MEMBRANES A Dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Biomedical Sciences by Daniel Robert Dries Committee in charge: Professor Alexandra C. Newton, Chair Professor Joseph A. Adams Professor Edward A. Dennis Professor Elizabeth A. Komives Professor Palmer W. Taylor 2007 The Dissertation of Daniel Robert Dries is approved, and it is acceptable in quality and form for publication on microfilm. _____________________________________________________________________ _____________________________________________________________________ _____________________________________________________________________ _____________________________________________________________________ _____________________________________________________________________ Chair University of California, San Diego 2007 iii Dedicated to Bob and Lisa iv TABLE OF CONTENTS Page SIGNATURE PAGE......................................................................................................iii DEDICATION ...............................................................................................................iv
    [Show full text]
  • Identification of Mammalian Cell Signaling in Response to Plasma Membrane Perforation: Endocytosis of Listeria Monocytogenes and the Repair Machinery
    1 Identification of mammalian cell signaling in response to plasma membrane perforation: Endocytosis of Listeria monocytogenes and The Repair Machinery Dissertation Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Jonathan Gat-Tze Lam Graduate Program in Microbiology The Ohio State University 2018 Dissertation Committee Stephanie Seveau, Advisor Dan Wozniak John Gunn Li Wu 2 Copyrighted by Jonathan Gar-Tze Lam 2018 3 Abstract The animal plasma membrane is a semi-fluid structural platform that maintains cellular homeostasis by regulating the passage of ions and small molecules in and out of the cell and modulating cell signaling activities. Disruption of its barrier function via mechanical damage or perforation by a pore-forming toxin is quickly followed by a sudden influx of extracellular Ca2+, which triggers efficient plasma membrane repair processes, the mechanisms of which are, to date, not fully elucidated. Efforts to understand cellular responses to plasma membrane damage have resulted in several non- mutually exclusive models of repair, each realized by the use of various cell types damaged using approaches that attempt to replicate normal physiological damage (mechanical, osmotic, and sheer stress) or damage that occurs under infectious conditions (bacterial pore-forming toxins). In the context of infection, evolutionarily distinct pathogens including the parasite Trypanosoma cruzi, the Gram-positive bacterium Listeria monocytogenes, and the non- enveloped Adenovirus have been shown to damage the plasma membrane of non- professional phagocytic cells in order to co-opt the subsequent cellular responses to facilitate their entry into target cells.
    [Show full text]
  • UC San Diego UC San Diego Electronic Theses and Dissertations
    UC San Diego UC San Diego Electronic Theses and Dissertations Title Regulation of PHLPP and Akt signaling Permalink https://escholarship.org/uc/item/1ff6w0r6 Author Warfel, Noel Andrew Publication Date 2011 Peer reviewed|Thesis/dissertation eScholarship.org Powered by the California Digital Library University of California UNIVERSITY OF CALIFORNIA, SAN DIEGO Regulation of PHLPP and Akt signaling A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Biomedical Sciences by Noel Andrew Warfel Committee in charge: Professor Alexandra C. Newton, Chair Professor Steve F. Dowdy Professor Kun-Liang Guan Professor Tony Hunter Professor Jing Yang 2011 The Dissertation of Noel Andrew Warfel is approved, and it is acceptable in quality and form for publication on microfilm and electronically: Chair University of California, San Diego 2011 iii DEDICATION Dedicated to Meredith Warfel for her endless dedication, love, and support and being a constant source of inspiration Dedicated to Stephen and Barbara Warfel for their guidance throughout my life. Without their support and advice this would not have been possible. iv TABLE OF CONTENTS Signature Page……………………………………………………...…………...…….iii Dedication……………………………………………………………………………..iv Table of Contents…………………………………...………………………...………..v List of Figures……………………………………………………………..…..……....vi List of Tables…………………………………...………………………..…..……......ix Acknowledgements…………………………………………………….……..…...….x Vita…………………………………………………………………………....….......xii Abstract of the
    [Show full text]
  • Cell Signaling in Cancer: from Mechanisms to Therapy June 3 – 8, 2018 Steamboat Springs, Colorado
    Cell Signaling in Cancer: from Mechanisms to Therapy June 3 – 8, 2018 Steamboat Springs, Colorado Organizers: John Brognard National Cancer Institute Claus Jorgensen CRUK Manchester Institute Deborah Morrison National Cancer Institute Sunday, June 3, 2018 Time Title/Topic Event 4:00 p.m. – 9:00 p.m. Conference Registration 5:00 p.m. – 6:00 p.m. Welcome Reception 6:00 p.m. – 7:00 p.m. DINNER 7:15 p.m. Opening remarks Session 1: Novel Signaling Chair: Claus Jorgensen, CRUK MI Pathways 7:30 p.m. – 8:00p.m. Targeting SHP2 in Cancer Ben Neel, NYU 8:00 p.m. – 8:30 p.m. Histidine kinases are new Tony Hunter, Salk therapeutic targets in cancers. 8:30 p.m. – 9:00 p.m. Allosteric regulation of protein Susan Taylor, University of kinase signaling. California San Diego 9:00 p.m. – 9:30 p.m. The tumor suppressing kinome John Brognard, NIH and a novel driver kinase in head and neck cancer 10 May 2018 Monday, June 4, 2018 Time Title/Topic Event 7:30 a.m. – 9:00 a.m. BREAKFAST 7:30 a.m. – 12:00 p.m. Conference Registration 8:55 a.m. Additional Opening Remarks 9:00 a.m. – 12:00 p.m. Session 2: Dynamics of Kinase Chair: Ben Neel, NYU Signaling in Cancer 9:00 a.m. – 9:30 a.m. Substrate targeting by oncogenic Ben Turk, Yale Pim kinases 9:30 a.m. – 10:00 a.m. PHLPP Phosphatases in Opposing Alexandra Newton, UCSD Kinase Signaling 10:00 a.m – 10:30 a.m.
    [Show full text]
  • University of California, San Diego
    UNIVERSITY OF CALIFORNIA, SAN DIEGO PHLPP: A Novel Family of Phosphatases that are Critical Regulators of Intracellular Signaling Pathways A dissertation submitted in partial satisfaction of the requirements for the Doctor of Philosophy in Biomedical Sciences by John F. Brognard Jr. Committee in Charge: Professor Alexandra C. Newton, Chair Professor John M Carethers Professor Jack E Dixon Professor Steve F Dowdy Professor Tony Hunter 2008 Copyright 2008 John F. Brognard Jr. All Rights Reserved 2 The dissertation of John F. Brognard Jr. is approved and it is acceptable in quality and form for publication on microfilm: Chair University of California, San Diego 2008 iii Dedicated to Karen Brognard for her loving support and dedication during the many long hours spent pursuing research and preparing this dissertation. Dedicated to John and Donna Brognard for their never ending support throughout my life and career. Without their support and guidance this never would have been possible. “Pursue your passion” – John F. Brognard Sr. Dedicated to Dr. Alexandra Newton for her unfaltering optimism and impeccable mentoring skills. Through her many personal challenges she remained a guiding light for me through challenging times. iv TABLE OF CONTENTS Signature Page……………………………………………………………...…………iii Dedication…………………………………………………………………………..…iv Table of Contents………………………………………………………………………v List of Figures…………………………………………………………………………vi Acknowledgments……………………………………………………………………..ix Vita and Publications…………………………………………………………………..x Abstract……………………..………………………………………………………...xii Chapter 1 An Introduction to the Ser/Thr Phosphatase PHLPP …………...…...…..1 Chapter 2 PHLPP and a Second Isoform, PHLPP2, Differentially Attenuate the Amplitude of Akt Signaling by Regulating Distinct Akt Isoforms...20 Chapter 3 Identification and Functional Characterization of a novel PHLPP2 Variant in Breast Cancer: Impacts on Akt and PKC Phosphorylation....71 Chapter 4 The Three Ps of PHLPP: PH Domain, PKC, and the the PDZ binding motif…………………………………….
    [Show full text]
  • Updated Abstract Book CCR FYI Colloquium 2021 Final 4.19.21.Pdf
    The Center for Cancer Research Fellows and Young Investigators Steering Committee presents: 21st Annual From Mechanisms to Therapies: CCR-FYI Current Highlights in COLLOQUIUM Cancer Research Analysis Testing Treatment April 19–20, 2021 Program U.S. Department of Health & Human Services | National Institutes of Health 21st Annual Center for Cancer Research Fellows and Young Investigators (CCR-FYI) Colloquium 21st Annual Center for Cancer Research Fellows and Young Investigators (CCR- FYI) Colloquium SCHEDULE AND PROGRAM BOOK From Mechanisms to Therapies: Current Highlights in Cancer Research April 19th- 20th, 2021 For internal use only 21st Annual CCR Fellows and Young Investigators Colloquium 21st Annual Center for Cancer Research Fellows and Young Investigators (CCR-FYI) Colloquium Welcome Letter Welcome Colloquium Participants! On behalf of the NCI Center for Cancer Research Fellows and Young Investigators (CCR-FYI) Steering Committee and CCR-FYI Colloquium Subcommittee, we welcome you to the 21st Annual CCR-FYI Colloquium. The CCR-FYI strives to promote scientific, career, and personal success and growth among all postdoctoral fellows, clinical fellows, postbaccalaureate fellows, and graduate students on the NIH campuses. We are kindly assisted by the NCI’s Center for Cancer Research (CCR) Office of the Director and the Center for Cancer Training (CCT) Office of Training and Education, who work to enhance the intramural trainee experience. The CCR-FYI would like to thank Dr. Ned Sharpless, Dr. Glenn Merlino, Dr. William Dahut, Dr. Tom Misteli, Erika Ginsburg, Dr. Oliver Bogler for their continuing assistance and guidance. We would also like to thank Angela Jones from the Center for Cancer Training, Robert Montano and his team from the Center for Biomedical Informatics and Information Technology for providing us with the managerial and technical help, respectively.
    [Show full text]
  • Modulation of PI3K/PTEN Pathway Does Not Affect Catalytic Activity Of
    ANTICANCER RESEARCH 37 : 5415-5423 (2017) doi:10.21873/anticanres.11969 Modulation of PI3K/PTEN Pathway Does Not Affect Catalytic Activity of PDK1 in Jurkat Cells KEUM-JIN YANG 1, LONGZHEN PIAO 1,2 , SANGHEE SHIN 1, SO-YEON SHIN 1, YUWEN LI 1,3 , HYUNJI LEE 1, QUANGDON TRAN 1, JISOO PARK 1, SUNTAEK HONG 4, DEREK P. BRAZIL 5, BRIAN A. HEMMINGS 6, SEON-HWAN KIM 7 and JONGSUN PARK 1 1Metabolic Syndrome and Cell Signaling Laboratory, Department of Pharmacology and Medical Science, Institute for Cancer Research, and 7Department of Neurosurgery, Institute for Cancer Research, College of Medicine, Chungnam National University, Daejeon, Republic of Korea; 2Department of Oncology, Yanbian University Hospital, Yanji, P.R. China; 3Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi’an, P.R. China; 4Laboratory of Cancer Cell Biology, Department of Biochemistry, School of Medicine, Gachon University, Incheon, Republic of Korea; 5Centre for Experimental Medicine, Queen's University Belfast, Belfast, Northern Ireland, U.K.; 6Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland Abstract. Unopposed phosphoinositide 3-kinase (PI3K) We demonstrated that reducing the level of 3- activity and 3-phosphoinositide production in Jurkat cells, phosphoinositides in Jurkat cells with pharmacological due to a mutation in the phosphatase and tensin homolog inhibitors of PI3K or expression of PTEN does not affect deleted on chromosome 10 (PTEN) tumor-suppressor PDK1 activity or its intracellular localization. We conclude, protein, results in deregulation of PH domain-containing therefore, that although Jurkat cells lack PTEN expression, proteins including the serine/threonine kinase PKB. In Jurkat only a subset of pathways downstream of PDK1 are cells, PKB is constitutively active and phosphorylated at the perturbed as a consequence of PTEN loss.
    [Show full text]
  • UNIVERSITY of CALIFORNIA, SAN DIEGO Molecular Mechanisms Of
    UNIVERSITY OF CALIFORNIA, SAN DIEGO Molecular Mechanisms of Atypical Protein Kinase C Regulation in Insulin Signaling A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Biomedical Sciences by Irene Sophie Tobias Committee in charge: Professor Alexandra Newton, Chair Professor Jack Dixon Professor Steve Dowdy Professor Tracy Handel Professor Joann Trejo 2016 Copyright Irene Sophie Tobias, 2016 All rights reserved The Dissertation of Irene Sophie Tobias is approved, and it is acceptable in quality and form for publication on microfilm and electronically: Chair University of California, San Diego 2016 iii DEDICATION For the Honor of Grayskull iv EPIGRAPH The ability to adapt to new information and hypotheses, to give up old dogmas, to admit that you are wrong, that is what separates the scientifically minded from the moronic masses of automatons. Mat Lalonde, PhD v TABLE OF CONTENTS SIGNATURE PAGE.....................................................................................................iii DEDICATION ..............................................................................................................iv EPIGRAPH..................................................................................................................... v TABLE OF CONTENTS ..............................................................................................vi LIST OF ABBREVIATIONS .....................................................................................viii LIST OF FIGURES.......................................................................................................
    [Show full text]
  • Protein Kinase Activation
    SEE INSIDE FOR 2008 ANNUAL MEETING SESSION OVERVIEWS July 2007 Protein Kinase Activation American Society for Biochemistry and Molecular Biology POSTDOCTORAL FELLOWSHIP Department of Dermatology, OHSU, Portland, Oregon Training Program in Molecular Basis of Skin Pathobiology Promoting Understanding Position for recent PhD, MD/PhD or MD (US citizen or Permanent Resident) in NIH-funded program for training highly of the Molecular Nature qualifi ed candidates for academic careers in basic & translational research in skin diseases, including cancer & psoriasis. OHSU Dermatology has a strong history of clinical & scientifi c of Life Processes research & a 40-year record in training dermatology residents including physician scientists & postdoctoral scientists on the path to independence. Features of this training program are a core of Dermatology faculty & a multidisciplinary network of scientists with international recognition in areas highly relevant to epithelial cell fate, development & diseases. The training program includes seminars in mentors’ departments, Dermatology Research Division meetings & symposia, research forums tailored to postdoctoral students, & national/international meetings in cutaneous biology. Successful candidates desiring an academic career in basic or translational research in cancer The Society’s purpose is to or investigative dermatology using surface epithelial models can advance the science of bio- expect to receive training toward independence in research with chemistry & molecular biology a strong clinical translational
    [Show full text]